We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XWhite Paper
November 4, 2022
In-depth analysis of immune responses to SARS-CoV-2 is essential for vaccine development and optimisation of immunisation strategies. A trio of new assays from EUROIMMUN for quantification of anti-S1/receptor binding domain IgG antibodies, detection of neutralising antibodies targeting S1/RBD, and analysis of specific T-cell responses supports the differentiated investigation of SARSCoV- 2-specific immune responses.
Download to find out more.